E-LIB Suche - Ergebnisse für: Gottlieb, A.B.

1

P50 Increasingly Stringent Clinical Responses and the Assoc..:

Gottlieb, A.B. ; Mørup, M. ; Davis, L....
Value in Health. 27 (2024) 6 - p. S12 , 2024

Link: https://doi.org/10.1016/..

2

CO13 A Claims Analysis To Characterize All-Cause Mortality ..:

Gottlieb, A.B. ; Kwiatkowski, H. ; Lavasani, L...
Value in Health. 27 (2024) 6 - p. S18 , 2024

Link: https://doi.org/10.1016/..

3

EE162 A Claims Analysis to Characterize the Economic Burden..:

Gottlieb, A.B. ; Lavasani, L ; Kwiatkowski, H.
Value in Health. 27 (2024) 6 - p. S87 , 2024

Link: https://doi.org/10.1016/..

4

Analyse intégrée, issue de 26 études cliniques, des infecti..:

Schwartzman, S. ; Puig, L. ; Cohen, A.D....
Revue du Rhumatisme. 90 (2023) - p. A165-A166 , 2023

Link: https://doi.org/10.1016/..

5

MSR85 Psoriasis Symptoms and Impacts Measure: Identifying K..:

Warren, R.B. ; Augustin, M. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S409 , 2023

Link: https://doi.org/10.1016/..

6

Health‐related quality of life in patients with generalized..:

Choon, S. E. ; De La Cruz, C. ; Wolf, P....
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 2 - p. 265-280 , 2023

Link: https://doi.org/10.1111/..

7

MSR52 Defining Severity Category Thresholds to Guide Psoria..:

Augustin, M. ; Gottlieb, A.B. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S402-S403 , 2023

Link: https://doi.org/10.1016/..

8

Le bimékizumab améliore la qualité de vie chez les patients..:

Gossec, L. ; Gladman, D.D. ; Kristensen, L.E....
Revue du Rhumatisme. 89 (2022) - p. A39-A40 , 2022

Link: https://doi.org/10.1016/..

9

Le bimékizumab chez des patients atteints de rhumatisme pso..:

Gossec, L. ; McInnes, I.B. ; Coates, L.C....
Revue du Rhumatisme. 89 (2022) - p. A74-A75 , 2022

Link: https://doi.org/10.1016/..

10

Amélioration durable de la fonction physique, de l'impact d..:

Gossec, L. ; Asahina, A. ; Gottlieb, A.B....
Revue du Rhumatisme. 88 (2021) - p. A26-A28 , 2021

Link: https://doi.org/10.1016/..

11

Efficacy of secukinumab and adalimumab in patients with pso..:

Gottlieb, A.B. ; Merola, J.F. ; Reich, K....
British Journal of Dermatology. 185 (2021) 6 - p. 1124-1134 , 2021

Link: https://doi.org/10.1111/..

12

Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis:..:

Blauvelt, A ; Paul, C ; Van de Kerkhof, P...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 5 - p. s46 , 2020

Link: https://doi.org/10.25251..

13

PBI56 Psychometric Validation of the P-SIM, a NOVEL Patient..:

Warren, R.B. ; Gottlieb, A.B. ; Merola, J.F....
Value in Health. 23 (2020) - p. S420 , 2020

Link: https://doi.org/10.1016/..

14

Long‐term efficacy of certolizumab pegol for the treatment ..:

Gordon, K.B. ; Warren, R.B. ; Gottlieb, A.B....
British Journal of Dermatology. 184 (2020) 4 - p. 652-662 , 2020

Link: https://doi.org/10.1111/..

15

Certolizumab Pegol for Treatment of Plaque Psoriasis: Poole..:

Gordon, K ; Warren, R B ; Gottlieb, A B...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 5 - p. s44 , 2020

Link: https://doi.org/10.25251..